Tore K Kvien & Guro L Goll argue that biosimilars are an opportunity for improving access to treatment & reducing cost and provide comment on the NOR-SWITCH study.
No posts to display
Advertisements
Latest Academic Articles
The latest academic articles from key research stakeholders